Brazilian antitrust watchdog CADE approved with no restriction the takeover of medical diagnostics company Alliar by an investment fund linked to tycoon Nelson Tanure, the country’s official gazette showed on Friday.
Controlling shareholders of Alliar announced in November they had accepted Tanure’s bid of 20.50 reais ($3.76) per share in the company, formally known as Centro de Imagem Diagnosticos SA.
Alliar said in a securities filing that CADE’s decision will be binding after a 15-day period starting on Friday, provided there are no challenges to the body’s ruling on the transaction.
Still, the closing of the deal depends on “the completion of other normal conditions precedent for this type of transaction,” it added.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI